BioFactura

Bio Factura

Biotechnology, 8435 Progress Dr, Frederick, Maryland, 21701, United States, 11-50 Employees

biofactura.com

  • facebook
  • LinkedIn

phone no Phone Number: 30********

Who is BIOFACTURA

BioFactura develops and commercializes biodefense drugs, novel drugs, and high-value biosimilars (i.e., follow-on biologics or generic biopharmaceuticals) using its patented StableFastTM ...

Read More

map
  • 8435 Progress Dr, Frederick, Maryland, 21701, United States Headquarters: 8435 Progress Dr, Frederick, Maryland, 21701, United States
  • 2003 Date Founded: 2003
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $5 Million to $10 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 8731 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from BIOFACTURA

BioFactura Org Chart and Mapping

Employees

Brianna Eddy

Document Control and Training Specialist

Cally Zanarini

Associate Director Manufacturing Operations

David A

Director of Cell Line Development

Eric Omdahl

Senior Manager Quality Control

Torre Montoya

Scientist (Analytical Development/Qc)

Christina Fiaschetti

Associate Director Upstream Process Development

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding BioFactura

Answer: BioFactura's headquarters are located at 8435 Progress Dr, Frederick, Maryland, 21701, United States

Answer: BioFactura's phone number is 30********

Answer: BioFactura's official website is https://biofactura.com

Answer: BioFactura's revenue is $5 Million to $10 Million

Answer: BioFactura's SIC: 8731

Answer: BioFactura's NAICS: 541714

Answer: BioFactura has 11-50 employees

Answer: BioFactura is in Biotechnology

Answer: BioFactura contact info: Phone number: 30******** Website: https://biofactura.com

Answer: BioFactura develops and commercializes biodefense drugs, novel drugs, and high-value biosimilars (i.e., follow-on biologics or generic biopharmaceuticals) using its patented StableFastTM Biomanufacturing Platform, the optimal choice for bringing these products to market with faster, lower cost, superior-quality manufacture. For over 10 years, BioFactura has been advancing life-saving medicines from the research bench to the patient using its innovative drug development and manufacturing technologies. Current and past programs include biodefense drugs against smallpox and Ebola, novel medicines for cancer, and low-cost/high-quality biosimilars for autoimmune and infectious diseases.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access